The U.S. cardiac resynchronization therapy market was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Surge in ...
A step-by-step, evidence-informed framework for interpreting high coronary calcium CT results, refining cardiovascular risk, and implementing integrative pr ...
Larry Allen, MD, MHS, and Kenneth B Margulies, MD, discuss HF management for American Heart Month and Heart Failure Awareness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results